mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PYCR1
Gene summary
Basic gene Info.Gene symbolPYCR1
Gene namepyrroline-5-carboxylate reductase 1
SynonymsARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR
CytomapUCSC genome browser: 17q25.3
Type of geneprotein-coding
RefGenesNM_001282279.1,
NM_001282280.1,NM_001282281.1,NM_006907.3,NM_153824.2,
DescriptionP5C reductase 1proliferation-inducing protein 45pyrroline-5-carboxylate reductase 1, mitochondrial
Modification date20141207
dbXrefs MIM : 179035
HGNC : HGNC
Ensembl : ENSG00000183010
HPRD : 01528
Vega : OTTHUMG00000178436
ProteinUniProt: P32322
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PYCR1
BioGPS: 5831
PathwayNCI Pathway Interaction Database: PYCR1
KEGG: PYCR1
REACTOME: PYCR1
Pathway Commons: PYCR1
ContextiHOP: PYCR1
ligand binding site mutation search in PubMed: PYCR1
UCL Cancer Institute: PYCR1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006561proline biosynthetic process16730026


Top
Ligand binding site mutations for PYCR1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
V231S233FBLCA1
L11F13VSTAD1
A97V99IUCEC1
A97V99AUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PYCR1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
L11F13V-0.60786334
A97V99A-0.53823081
V231S233F-0.49454595
A97V99I-0.15460129
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PYCR1 from PDB

Top
Differential gene expression and gene-gene network for PYCR1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PYCR1 and the right PPI network was created from samples without mutations in the LBS of PYCR1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PYCR1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C2751987Cutis Laxa, Autosomal Recessive, Type IIB4Biomarker, GeneticVariation
umls:C0010495Cutis Laxa3Biomarker
umls:C0033300Progeria1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PYCR1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
NutraceuticalDB00157NADHSmall molecule
Approved|nutraceuticalDB00172L-ProlineSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PYCR1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NADNAD ZWITTERION2izzAL11 A97
NADNAD ZWITTERION2izzBL11 A97
NADNAD ZWITTERION2izzCL11 A97
NADNAD ZWITTERION2izzDL11 A97
NADNAD ZWITTERION2izzEL11 A97
NADNAD ZWITTERION2izzAV231
NADNAD ZWITTERION2izzBV231
NADNAD ZWITTERION2izzCV231


Top
Conservation information for LBS of PYCR1
Multiple alignments for P32322 in multiple species
LBSAA sequence# speciesSpecies
A69DVLFLAVKPHI3Homo sapiens, Bos taurus, Mus musculus
A8VGFIGAGQLAF3Homo sapiens, Bos taurus, Mus musculus
A96IVVSCAAGVTI3Homo sapiens, Bos taurus, Mus musculus
A97VVSCAAGVTIS2Homo sapiens, Bos taurus
A97VVSCAAGVTIN1Mus musculus
C95HIVVSCAAGVT3Homo sapiens, Bos taurus, Mus musculus
E130PVVVREGATVY2Homo sapiens, Bos taurus
E130PVVVREGVTVY1Mus musculus
E221MLLHSEQHPGQ1Homo sapiens
E221MLLDSEQHPGQ1Bos taurus
E221MLLDSEQHPSQ1Mus musculus
F158LSSVGFCTEVE1Homo sapiens
F158MSSVGFCTEVE1Bos taurus
F158MGSVGFCTEVE1Mus musculus
G157LLSSVGFCTEV1Homo sapiens
G157LMSSVGFCTEV1Bos taurus
G157LMGSVGFCTEV1Mus musculus
G7SVGFIGAGQLA3Homo sapiens, Bos taurus, Mus musculus
G9GFIGAGQLAFA3Homo sapiens, Bos taurus, Mus musculus
H219AKMLLDSEQHP2Bos taurus, Mus musculus
H219AKMLLHSEQHP1Homo sapiens
I6MSVGFIGAGQL3Homo sapiens, Bos taurus, Mus musculus
I74AVKPHIIPFIL3Homo sapiens, Bos taurus, Mus musculus
I78HIIPFILDEIG2Homo sapiens, Mus musculus
I78HIIPFILDEIA1Bos taurus
K215LLGAAKMLLDS2Bos taurus, Mus musculus
K215LLGAAKMLLHS1Homo sapiens
K71LFLAVKPHIIP3Homo sapiens, Bos taurus, Mus musculus
L11IGAGQLAFALA3Homo sapiens, Bos taurus, Mus musculus
L217GAAKMLLDSEQ2Bos taurus, Mus musculus
L217GAAKMLLHSEQ1Homo sapiens
L218AAKMLLDSEQH2Bos taurus, Mus musculus
L218AAKMLLHSEQH1Homo sapiens
L39SPDMDLATVSA2Homo sapiens, Bos taurus
L39SPDMDQATVSA1Mus musculus
M121KVIRCMTNTPV2Bos taurus, Mus musculus
M121RVIRCMTNTPV1Homo sapiens
N230GQLKDNVSSPG1Homo sapiens
N230GQLKDNVCSPG1Bos taurus
N230SQLKDNVCSPG1Mus musculus
N56KLTPHNKETVQ1Homo sapiens
N56NLTHHNKETVQ1Bos taurus
N56NLTPHNKETVR1Mus musculus
P35IMASSPDMDLA2Homo sapiens, Bos taurus
P35IMASSPDMDQA1Mus musculus
P72FLAVKPHIIPF3Homo sapiens, Bos taurus, Mus musculus
Q10FIGAGQLAFAL3Homo sapiens, Bos taurus, Mus musculus
R129TPVVVREGATV2Homo sapiens, Bos taurus
R129TPVVVREGVTV1Mus musculus
S154MEQLLSSVGFC1Homo sapiens
S154LEQLMSSVGFC1Bos taurus
S154VEQLMGSVGFC1Mus musculus
S155EQLLSSVGFCT1Homo sapiens
S155EQLMSSVGFCT1Bos taurus
S155EQLMGSVGFCT1Mus musculus
S220KMLLHSEQHPG1Homo sapiens
S220KMLLDSEQHPG1Bos taurus
S220KMLLDSEQHPS1Mus musculus
S34KIMASSPDMDL2Homo sapiens, Bos taurus
S34KIMASSPDMDQ1Mus musculus
T122VIRCMTNTPVV3Homo sapiens, Bos taurus, Mus musculus
T124RCMTNTPVVVR3Homo sapiens, Bos taurus, Mus musculus
V156QLLSSVGFCTE1Homo sapiens
V156QLMSSVGFCTE1Bos taurus
V156QLMGSVGFCTE1Mus musculus
V231QLKDNVCSPGG2Bos taurus, Mus musculus
V231QLKDNVSSPGG1Homo sapiens
V70VLFLAVKPHII3Homo sapiens, Bos taurus, Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas